ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2519

Characteristics of Eye Diseases in Patients with Ankylosing Spondylitis in Korea: A Single-Center Survey

Seunghun Lee1, Bon San Koo2, Ji Hui Shin3 and Tae-Hwan Kim4, 1Department of Radiology, Hanyang University Hospital, Seoul, Korea, Republic of (South), 2rheumatology, Inje University College of Medicine, seoul, Korea, Republic of (South), 3rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South), 4Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea, Republic of (South)

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Ankylosing spondylitis (AS), eye disease and uveitis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster III: Outcomes, Outcome Measures, and Comorbidities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Uveitis is the most common extra-articular manifestation occurring in patients with ankylosing spondylitis (AS). The purpose of this study is to evaluate the characteristics of uveitis in patients with AS using questionnaire survey.

Methods: A questionnaire-based survey was conducted for patients enrolled in AS registry at a rheumatology clinic in a tertiary hospital between September 2015 and December 2015. Patients responded to 10 questions, with several sub-questions related to eye disease including uveitis.

Results: A total of 750 patients participated in the survey. Among them, 266 (35%) answered that they had an eye disease including uveitis (64%), conjunctivitis (8%), dry eye (6%), and iritis (5%). The number of patients who were diagnosed with uveitis in the ophthalmology department was 218 (29%). The number of patients who experienced a flare of uveitis more than once a year was 109 (50%). In addition, at the time of the study, only 53 (24%) had been recommended to undergo testing for autoimmune disease. The most common symptoms of patients with uveitis were ocular congestion (61%), eye pain (54%), and decreased visual acuity (51%). Interestingly, 91 of the 532 patients (17%) who had not been diagnosed with uveitis before also experienced similar symptoms.

Conclusion:

We identified various eye-related problems and the clinical characteristics of uveitis in patients with AS. Our survey revealed not only information about AS-related eye diseases but also the need for cooperation between rheumatologists and ophthalmologists.


Disclosure: S. Lee, None; B. S. Koo, None; J. H. Shin, None; T. H. Kim, None.

To cite this abstract in AMA style:

Lee S, Koo BS, Shin JH, Kim TH. Characteristics of Eye Diseases in Patients with Ankylosing Spondylitis in Korea: A Single-Center Survey [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/characteristics-of-eye-diseases-in-patients-with-ankylosing-spondylitis-in-korea-a-single-center-survey/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characteristics-of-eye-diseases-in-patients-with-ankylosing-spondylitis-in-korea-a-single-center-survey/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology